Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.

Cell Biol Toxicol · 2023 · PMC10406704 · PMID 34519926

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, both cell lines showed a trend towards higher pCHK2/CHK2 when treated with Dox and PX compared with Dox alone, suggesting a potential activation of the ATM-CHK2 signaling.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.